GLOBUS MED INC's ticker is GMED and the CUSIP is 379577208. A total of 371 filers reported holding GLOBUS MED INC in Q4 2021. The put-call ratio across all filers is 0.49 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $518 | +46.3% | 10,424 | +75.3% | 0.00% | 0.0% |
| Q2 2023 | $354 | +2.3% | 5,948 | -2.7% | 0.00% | 0.0% |
| Q1 2023 | $346 | -24.0% | 6,112 | -0.4% | 0.00% | 0.0% |
| Q4 2022 | $455 | -99.9% | 6,137 | -2.7% | 0.00% | 0.0% |
| Q3 2022 | $375,000 | +6.2% | 6,308 | +0.3% | 0.00% | 0.0% |
| Q2 2022 | $353,000 | -28.4% | 6,288 | -6.1% | 0.00% | 0.0% |
| Q1 2022 | $493,000 | -8.2% | 6,693 | -10.2% | 0.00% | 0.0% |
| Q4 2021 | $537,000 | +15.7% | 7,451 | +23.0% | 0.00% | 0.0% |
| Q3 2021 | $464,000 | +34.1% | 6,058 | +35.5% | 0.00% | 0.0% |
| Q2 2021 | $346,000 | +31.1% | 4,471 | +4.1% | 0.00% | 0.0% |
| Q1 2021 | $264,000 | -12.3% | 4,296 | -7.0% | 0.00% | 0.0% |
| Q4 2020 | $301,000 | +29.2% | 4,621 | -1.8% | 0.00% | 0.0% |
| Q3 2020 | $233,000 | -2.1% | 4,706 | -6.0% | 0.00% | 0.0% |
| Q2 2020 | $238,000 | – | 5,006 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 908,953 | $59,282,000 | 5.54% |
| Sterling Investment Advisors, Ltd. | 234,623 | $15,302,000 | 5.20% |
| Next Capital Management LLC | 111,098 | $7,246,000 | 5.10% |
| Godshalk Welsh Capital Management, Inc. | 77,085 | $5,027,000 | 3.71% |
| Pembroke Management, LTD | 613,931 | $40,041,000 | 3.36% |
| XXEC, Inc. | 52,800 | $3,444,000 | 2.71% |
| Global Alpha Capital Management Ltd. | 302,377 | $19,721,000 | 2.42% |
| Van Berkom & Associates Inc. | 1,572,303 | $102,546,000 | 2.35% |
| PARADIGM CAPITAL MANAGEMENT INC/NY | 581,700 | $37,939,000 | 2.27% |
| RTW INVESTMENTS, LP | 1,640,859 | $107,017,000 | 1.80% |